Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Thomas Scanlan
Oregon Health & Science University, Department: Physiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeuroVia, Inc.
Other : Licensed technology through our institution (OHSU considers SFI)
Please see the attached pdf
Thyroid Hormone Action
PROJECT NARRATIVE This research seeks to design, synthesize, and characterize novel thyroid hormone receptor (TR) ligands that have selective actions in the central nervous system (CNS). There are several CNS disorders that might benefit from stimulation of thyroid hormone signaling pathways, but most if not all of the known TR ligands do not possess the necessary safety margin separating the stimulation of desired thyroid action in the CNS from undesired actions in non-CNS tissues. Our approach involves the development of a pro-drug strategy that masks the TR ligand making it inactive in blood and non-CNS tissue. However, upon accessing the CNS by penetration of the blood-brain-barrier, the pro-drug protection is unmasked revealing the active TR ligand. The purpose of this research is to test and validate this approach to generate new thyroid hormone based research tools and drugs for use in the CNS.
Filed on February 03, 2017.
Tell us what you know about Thomas Scanlan's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Thomas Scanlan filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Thomas Scanlan | Oregon Health & Science University | Conflict of Interest | NeuroVia, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.